| |
TOBISHI PHARMACEUTICAL CO.,LTD.
【EST.DATE】July 13.1959
【ADDRESS】
- Head office
Yurakucho Bldg, 10-1, Yurakucho 1-chome,Chiyoda-ku, Tokyo
- Ome plant
3-4, Suehirocho 1-chome, Ome, Tokyo
- Ome laboratory
7-1, Suehirocho 1-chome, Ome, Tokyo
- Osaka office
Menshi Kaikan 4-7, Uchiawajimachi 1-chome,Chuo-ku, Osaka
【BUSINESS】
Manufacturing, sales and marketing of pharmaceuticals
【CAPITAL】\163,000,000
【DIRECTORS】
President SENGA, Hirobumi
【HISTORY】
- Jul.1959
- Established as a pharmaceutical importing company with capital
of \3 million.
- Mar.1963
- Constructed Ochiai plant and started domestic production.
- Jul.1963
- Capital increased to \12 million.
- Feb.1964
- Constructed Omori plant.
- Jul.1964
- Separated sales division and established Tobishi Shinyaku Co.,Ltd.
- Aug.1964
- Capital increased to \24 million.
- Dec.1964
- Constructed Koganei laboratory.
- Aug.1965
- Capital increased to \48 million.
- Dec.1966
- Moved to present office Building(Chiyoda-ku,Tokyo).
- Jun.1967
- Constructed Ome plant.
- Aug.1967
- Constructed Omori laboratory.
- Mar.1969
- Established Osaka office.
- Nov.1969
- Constructed Itabashi plant.
- Apr.1978
- Constructed Omori laboratory.
- Oct.1986
- Capital increased to \163 million.
- Feb.1988
- Omori laboratory and koganei laboratory relocated at ome. The construction of Ome plant completed Ochiai plant and Omori
plant relocated at Ome.
- Feb.1989
- Ome No.4 plant constructed. Itabashi plant relocated at Ome.
- Mar.1992
- Central research Bldg. was constructed in Ome.
- Sep.1993
- Opened China head office (Beijing).
- Nov.1993
- Established Beijing Tobishi Pharmaceutical Co., Ltd.(Beijing).
- Apr.1995
- Established Beijing Yun Ling Bio-Technology Co.,Ltd.(Beijing).
- Aug.1997
- Established Tobishi GmbH(Freiburg).
- Jun.1998
- Established Tobishi(Hong Kong) Co., Ltd. Established Tobishi USA Inc.(Los Angeles).
- Jul.1998
- Established Tobishi Beijin Biomedical Technology Co.,Ltd.(Beijing).
【DOMESTIC AGENTS】
FUSO PHARMACEUTICAL INDUSTRIES,LTD.
TAIHO PHARMACEUTICAL CO.,LTD.
ZERIA PHARMACEUTICAL CO., LTD.
MARUKO SEIYAKU CO., LTD.
NIPPON CEMIPHAR CO., LTD.
SAWAI PHARMACEUTICAL CO., LTD.
NICHIIKO PHARMACEUTICAL CO., LTD.
MITSUBISHI KAGAKU IATRON, INC.
TEIKOKU MEDIX CO., LTD.
NIPRO GENEPHA CORPORATION
I,ROM PHARMACEUTICAL CO., LTD.
SANDOZ CO., LTD.
MIKASA SEIYAKU CO.,LTD.
【OVERSEAS FIRMS REPRESENTED BY TOBISHI】
SWITZERLAND
Legacy Pharmaceuticals Switzerland GmbH
- Solcoseryl Inj.
- Solcoseryl-Oint.
- Solcoseryl Vaginai Supp.
Pentapharm Ltd.
- Defibrase Inj.
- Reptilase-S Inj.
- Reselase
Pharmakon Ltd.
- Hemolingual Buc.Tab.
- Haemolind Buc.Tab.
SWEDEN
AB Cernelle
LIECHTENSTEIN
Phafag AG
|
|